Search results for rad51c

192 hits were found for rad51c

# Family MCID Name MIFTS Score
1
P TMR010 Tumor Predisposition Syndrome 69 136.861
2
CTN028 Cutaneous Telangiectasia and Cancer Syndrome, Familial 70 136.182
3
INH023 Inherited Cancer-Predisposing Syndrome 53 136.182
4
c FNC048 Fanconi Anemia, Complementation Group O 51 74.921
5
c FNC027 Fanconi Anemia, Complementation Group a 80 67.501
6
c BRS088 Breast-Ovarian Cancer, Familial 3 24 48.361
7
P HRD200 Hereditary Breast Ovarian Cancer Syndrome 67 43.282
8
P OVR042 Ovarian Cancer 88 36.531
9
P BRS047 Breast Cancer 97 36.082
10
c BRS110 Breast-Ovarian Cancer, Familial 1 57 20.797
11
c OVR114 Ovarian Cancer 1 60 17.935
12
HRD114 Hereditary Site-Specific Ovarian Cancer Syndrome 25 16.386
13
c FML353 Familial Ovarian Cancer 44 13.444
14
P MCR010 Microcephaly 59 12.101
15
PRM013 Premature Menopause 57 11.796
16
c SPR009 Sporadic Breast Cancer 42 10.707
17
FLL027 Fallopian Tube Carcinoma 66 9.969
18
MLB001 Mulibrey Nanism 51 9.824
19
GST103 Gastric Cancer, Hereditary Diffuse 68 9.226
20
P NNS032 Non-Syndromic X-Linked Intellectual Disability 46 8.861
21
c FNC023 Fanconi Anemia, Complementation Group N 48 8.167
22
c FNC024 Fanconi Anemia, Complementation Group D1 51 8.147
23
P LFR001 Li-Fraumeni Syndrome 73 8.127
24
P LYN001 Lynch Syndrome 76 7.754
25
c FNC025 Fanconi Anemia, Complementation Group J 52 7.642
26
c FNC046 Fanconi Anemia, Complementation Group P 49 7.302
27
c FNC057 Fanconi Anemia, Complementation Group U 42 7.237
28
c FNC047 Fanconi Anemia, Complementation Group Q 47 7.152
29
P APL001 Aplastic Anemia 72 7.092
30
P MRR011 Mirror Movements 1 51 7.092
31
c FNC058 Fanconi Anemia, Complementation Group R 43 7.092
32
P CWD010 Cowden Syndrome 70 7.092
33
PRT035 Peritoneum Cancer 45 6.947
34
FLL029 Fallopian Tube Disease 43 6.947
35
CLN018 Colon Sarcoma 29 6.947
36
FLL003 Fallopian Tube Endometrioid Adenocarcinoma 34 6.947
37
END057 Endometrial Cancer 76 2.577
38
P PRS040 Prostate Cancer 95 2.433
39
c BRS111 Breast-Ovarian Cancer, Familial 2 53 2.371
40
DFC004 Deficiency Anemia 74 2.283
41
P CLR023 Colorectal Cancer 100 2.177
42
c BRS098 Breast-Ovarian Cancer, Familial 4 29 1.974
43
c FNC042 Fanconi Anemia, Complementation Group D2 54 1.928
44
P GST053 Gastric Cancer 82 1.732
45
OVR094 Ovarian Epithelial Cancer 39 1.698
46
P PNC035 Pancreatic Cancer 87 1.614
47
BLT006 Bilateral Breast Cancer 48 1.574
48
ATX038 Ataxia and Polyneuropathy, Adult-Onset 45 1.539
49
SPN035 Spindle Cell Sarcoma 51 1.481
50
END031 Endometrial Stromal Sarcoma 45 1.461
51
SRC014 Sarcoma 64 1.461
52
P ATX030 Ataxia-Telangiectasia 80 1.459
53
c PRM196 Premature Ovarian Failure 1 58 1.394
54
BLD173 Bladder Small Cell Carcinoma 44 1.252
55
P FNC044 Fanconi Anemia, Complementation Group C 56 1.220
56
SML009 Small Intestine Adenocarcinoma 57 1.214
57
P LNG032 Lung Cancer 98 1.196
58
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 59 1.136
59
c CLR087 Colorectal Cancer 12 34 1.136
60
c SML038 Small Cell Cancer of the Lung 68 1.113
61
TLN003 Telangiectasis 51 1.113
62
P BLD134 Bladder Cancer 79 1.105
63
DPH001 Diphtheria 59 1.062
64
CLN015 Colon Adenocarcinoma 64 1.056
65
c FNC062 Fanconi Anemia, Complementation Group S 29 0.968
66
c LFR007 Li-Fraumeni Syndrome 2 45 0.968
67
PNC129 Pancreatic Adenocarcinoma 64 0.968
68
MRT001 Muir-Torre Syndrome 59 0.929
69
P HYP078 Hypertrophy of Breast 41 0.929
70
ANS023 Anus, Imperforate 56 0.883
71
SQM013 Squamous Cell Carcinoma, Head and Neck 75 0.883
72
HYP080 Hypogonadism 49 0.883
73
SQM006 Squamous Cell Carcinoma 59 0.883
74
P DFF019 Diffuse Gastric Cancer 50 0.883
75
P HLP001 Holoprosencephaly 68 0.883
76
PTS001 Patau Syndrome 55 0.883
77
BRR002 Barrett's Adenocarcinoma 37 0.883
78
CLF001 Cleft Lip 54 0.883
79
CHR178 Chromosomal Triplication 33 0.883
80
LBR025 Lobar Holoprosencephaly 47 0.883
81
CLF004 Cleft Lip/palate 56 0.883
82
c MSM022 Mismatch Repair Cancer Syndrome 1 69 0.824
83
GLM045 Glioma 62 0.824
84
P LKM071 Leukemia, Chronic Lymphocytic 74 0.823
85
GST040 Gastric Adenocarcinoma 66 0.803
86
c GLM043 Glioma Susceptibility 9 30 0.679
87
c GLM025 Glioma Susceptibility 2 30 0.679
88
c GLM047 Glioma Susceptibility 3 32 0.679
89
MNN043 Meningioma, Familial 79 0.679
90
P GLM040 Glioma Susceptibility 1 70 0.679
91
P LNG064 Lung Cancer Susceptibility 3 69 0.679
92
ADN011 Adenoid Cystic Carcinoma 68 0.679
93
P OLG002 Oligodendroglioma 66 0.679
94
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 0.679
95
LNG039 Lung Squamous Cell Carcinoma 57 0.679
96
ADN089 Adenosquamous Lung Carcinoma 51 0.679
97
LBL001 Lobular Neoplasia 54 0.679
98
P PRG013 Paraganglioma 57 0.678
99
MYC006 Mycosis Fungoides 64 0.678
100
LYN004 Lynch Syndrome I 60 0.598
101
BRS099 Breast Ductal Carcinoma 61 0.526
102
PPL004 Papillary Squamous Carcinoma 39 0.526
103
END041 Endometrial Adenocarcinoma 63 0.526
104
c FNC029 Fanconi Anemia, Complementation Group I 55 0.523
105
SZR001 Sezary's Disease 60 0.517
106
c 46X071 46,xy Disorder of Sexual Development Due to Dihydrotestosterone Backdoor Pathway Biosynthesis Defect 42 0.435
107
VNH007 Von Hippel-Lindau Syndrome 72 0.429
108
c PRS097 Prostate Cancer, Hereditary, 1 38 0.429
109
c PRS114 Prostate Cancer, Hereditary, 2 33 0.429
110
RNL114 Renal Cell Carcinoma, Nonpapillary 79 0.429
111
ESP021 Esophageal Cancer 84 0.429
112
c PRS070 Prostate Cancer, Hereditary, 12 22 0.429
113
c PRS071 Prostate Cancer, Hereditary, 13 25 0.429
114
c PRS117 Prostate Cancer, Hereditary, 11 24 0.429
115
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 33 0.429
116
CLR030 Clear Cell Renal Cell Carcinoma 53 0.429
117
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.429
118
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 28 0.429
119
P NJM001 Nijmegen Breakage Syndrome 75 0.410
120
HRD224 Hereditary Nonpolyposis Colon Cancer 51 0.410
121
NJM002 Nijmegen Breakage Syndrome-Like Disorder 39 0.384
122
c FNC028 Fanconi Anemia, Complementation Group L 46 0.324
123
P CLR037 Colorectal Cancer, Hereditary Nonpolyposis, Type 5 49 0.324
124
P MYL006 Myeloid Leukemia 60 0.324
125
ATX029 Ataxia, Early-Onset, with Oculomotor Apraxia and Hypoalbuminemia 60 0.290
126
c ATX040 Ataxia-Telangiectasia-Like Disorder 1 50 0.290
127
P NRF002 Neurofibromatosis 60 0.290
128
FML037 Female Breast Cancer 51 0.251
129
c FNC032 Fanconi Anemia, Complementation Group B 48 0.251
130
c FML347 Familial Adenomatous Polyposis 2 56 0.251
131
PNC041 Pancreatic Ductal Adenocarcinoma 51 0.251
132
P ATT003 Attenuated Familial Adenomatous Polyposis 57 0.251
133
47X002 47,xyy 47 0.251
134
MYH016 Myh-Associated Polyposis 39 0.251
135
MTY003 Mutyh Polyposis 39 0.251
136
P MDL005 Medulloblastoma 75 0.205
137
PTZ001 Peutz-Jeghers Syndrome 69 0.205
138
c FNC043 Fanconi Anemia, Complementation Group E 62 0.205
139
c LFR009 Li-Fraumeni Syndrome 1 32 0.205
140
P LKM002 Leukemia 65 0.205
141
P ADN016 Adenocarcinoma 63 0.205
142
CVD001 Covid-19 59 0.205
143
P NRB001 Neuroblastoma 66 0.205
144
EST002 Estrogen-Receptor Negative Breast Cancer 45 0.145
145
MYL009 Myelodysplastic Syndrome 67 0.145
146
SPL004 Splenic Marginal Zone Lymphoma 50 0.145
147
P LYM118 Lymphoma 66 0.145
148
P CTN015 Cutaneous T Cell Lymphoma 48 0.145
149
P EST001 Estrogen-Receptor Positive Breast Cancer 49 0.145
150
P ALZ034 Alzheimer Disease 87 0.145
151
c WLM013 Wilms Tumor 1 65 0.145
152
c NRF024 Neurofibromatosis, Type I 76 0.145
153
c MLT160 Multiple Endocrine Neoplasia, Type Iia 67 0.145
154
MLT161 Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia, and Hydranencephaly 55 0.145
155
c WLM018 Wilms Tumor 5 53 0.145
156
c LKM061 Leukemia, Acute Myeloid 83 0.145
157
AGN016 Aging 53 0.145
158
c FNC052 Fanconi Anemia, Complementation Group T 41 0.145
159
c HRM009 Hermansky-Pudlak Syndrome 6 46 0.145
160
c SLV029 Silver-Russell Syndrome 2 26 0.145
161
P TST021 Testicular Germ Cell Tumor 61 0.145
162
LMY014 Leiomyoma, Uterine 55 0.145
164
c LKM063 Leukemia, Chronic Myeloid 70 0.145
165
c CCK007 Cockayne Syndrome B 56 0.145
166
NND010 Nondisjunction 34 0.145
167
MNT001 Mantle Cell Lymphoma 65 0.145
168
LWG006 Low Grade Glioma 41 0.145
169
MRG003 Marginal Zone B-Cell Lymphoma 52 0.145
170
TRN018 Transitional Cell Carcinoma 56 0.145
171
GLB002 Glioblastoma 67 0.145
172
P FBR017 Fibrosarcoma 55 0.145
173
NRN004 Neuroendocrine Tumor 55 0.145
174
c BRD011 Bardet-Biedl Syndrome 10 49 0.145
175
SMN007 Seminoma 42 0.145
176
CRC021 Carcinosarcoma 62 0.145
177
P CCK001 Cockayne Syndrome 67 0.145
178
ALL029 Allergic Disease 61 0.145
179
HYD002 Hydronephrosis 58 0.145
180
BRN028 Brain Cancer 73 0.145
181
P MLN008 Melanoma 75 0.145
182
P BCL017 B-Cell Lymphoma 57 0.145
183
P INS002 in Situ Carcinoma 52 0.145
184
GRM010 Germ Cells Tumors 33 0.145
185
TST043 Testicular Seminoma 31 0.145
186
PLY100 Polyploidy 36 0.145
187
P PRC019 Precocious Puberty 48 0.145
188
P RRT020 Rare Tumor 39 0.145
189
DWR001 Dwarfism 44 0.145
190
P INH011 Inherited Bone Marrow Failure Syndromes 33 0.145
191
GLL048 Glial Tumor 51 0.145
192
THY029 Thyroid Carcinoma 55 0.145
Content
Loading form....